PEMEDIC

PEMEDIC has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €600,072 and a net result of €369,241. Equity is growing by about 9.1% per year across the filed financial years. Its solvency ranks better than 53% of 20,558 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).